What happened Anavex Life Sciences Corp. (NASDAQ: AVXL) said the FDA notified it that the company may proceed with its planned Fragile X study. The IND for ANAVEX 2-73, also called blarcamesine, is now open in the United States. Anavex said it now has open INDs in Alzheimer's disease, Rett syndrome and Fragile X syndrome. […]